These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22160344)

  • 1. Detection of bioactive exometabolites produced by the filamentous marine cyanobacterium Geitlerinema sp.
    Caicedo NH; Kumirska J; Neumann J; Stolte S; Thöming J
    Mar Biotechnol (NY); 2012 Aug; 14(4):436-45. PubMed ID: 22160344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antialgal, antibacterial and antifungal activity of two metabolites produced and excreted by cyanobacteria during growth.
    Volk RB; Furkert FH
    Microbiol Res; 2006; 161(2):180-6. PubMed ID: 16427523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of biphenyl by the cyanobacterium, Oscillatoria sp., strain JCM.
    Cerniglia CE; Van Baalen C; Gibson DT
    Arch Microbiol; 1980 Apr; 125(3):203-7. PubMed ID: 6769418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collection, Culturing, and Genome Analyses of Tropical Marine Filamentous Benthic Cyanobacteria.
    Moss NA; Leao T; Glukhov E; Gerwick L; Gerwick WH
    Methods Enzymol; 2018; 604():3-43. PubMed ID: 29779657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.
    Tan LT; Phyo MY
    Molecules; 2020 May; 25(9):. PubMed ID: 32397127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Genomics of Cyanobacterial Symbionts Reveals Distinct, Specialized Metabolism in Tropical
    Schorn MA; Jordan PA; Podell S; Blanton JM; Agarwal V; Biggs JS; Allen EE; Moore BS
    mBio; 2019 May; 10(3):. PubMed ID: 31088928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picocyanobacteria from a clade of marine Cyanobium revealed bioactive potential against microalgae, bacteria, and marine invertebrates.
    Costa MS; Costa M; Ramos V; Leão PN; Barreiro A; Vasconcelos V; Martins R
    J Toxicol Environ Health A; 2015; 78(7):432-42. PubMed ID: 25785557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chemistry, Biochemistry and Pharmacology of Marine Natural Products from
    Li Y; Naman CB; Alexander KL; Guan H; Gerwick WH
    Mar Drugs; 2020 Oct; 18(10):. PubMed ID: 33036172
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel toxic effects associated with a tropical Limnothrix/Geitlerinema-like cyanobacterium.
    Bernard C; Froscio S; Campbell R; Monis P; Humpage A; Fabbro L
    Environ Toxicol; 2011 Jun; 26(3):260-70. PubMed ID: 19950362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moorea producens gen. nov., sp. nov. and Moorea bouillonii comb. nov., tropical marine cyanobacteria rich in bioactive secondary metabolites.
    Engene N; Rottacker EC; Kaštovský J; Byrum T; Choi H; Ellisman MH; Komárek J; Gerwick WH
    Int J Syst Evol Microbiol; 2012 May; 62(Pt 5):1171-1178. PubMed ID: 21724952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese coast: high potential as a source of anticancer compounds.
    Costa M; Garcia M; Costa-Rodrigues J; Costa MS; Ribeiro MJ; Fernandes MH; Barros P; Barreiro A; Vasconcelos V; Martins R
    Mar Drugs; 2013 Dec; 12(1):98-114. PubMed ID: 24384871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of sea microalgae exometabolites on reproduction of pathogenic bacteria].
    Buzoleva LS; Terekhova VE; Krivosheeva AM; Aĭzdaĭcher NA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):96-9. PubMed ID: 20468099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive compounds from Pseudanabaena species (Cyanobacteria).
    Oufdou K; Mezrioui N; Oudra B; Loudiki M; Barakate M; Sbiyyâa B
    Microbios; 2001; 106 Suppl 1():21-9. PubMed ID: 11549237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out in the green: biologically active metabolites produced by cyanobacteria.
    Gademann K
    Chimia (Aarau); 2011; 65(6):416-9. PubMed ID: 21797171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New tricks from ancient algae: natural products biosynthesis in marine cyanobacteria.
    Jones AC; Gu L; Sorrels CM; Sherman DH; Gerwick WH
    Curr Opin Chem Biol; 2009 Apr; 13(2):216-23. PubMed ID: 19307147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Physiological Roles of the Cyanobacterium Geitlerinema sp. BBD and Other Black Band Disease Community Members through Genomic Analysis of a Mixed Culture.
    Den Uyl PA; Richardson LL; Jain S; Dick GJ
    PLoS One; 2016; 11(6):e0157953. PubMed ID: 27336619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of microalgae for species excreting norharmane, a manifold biologically active indole alkaloid.
    Volk RB
    Microbiol Res; 2008; 163(3):307-13. PubMed ID: 16872816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for hydrophilic marine fungal metabolites: a rational approach for their production and extraction in a bioactivity screening context.
    Le Ker C; Petit KE; Biard JF; Fleurence J
    Mar Drugs; 2011 Jan; 9(1):82-97. PubMed ID: 21339948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyanobacterial diversity in extreme environments in Baja California, Mexico: a polyphasic study.
    López-Cortés A; García-Pichel F; Nübel U; Vázquez-Juárez R
    Int Microbiol; 2001 Dec; 4(4):227-36. PubMed ID: 12051567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep-sea natural products.
    Skropeta D
    Nat Prod Rep; 2008 Dec; 25(6):1131-66. PubMed ID: 19030606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.